Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 16, Issue 5, 2009, Pages 668-674

  Jang, Jin Young ^a   Park, Yoon Chan ^b   Song, Yoon Sup ^a   Lee, Seung Eun ^a   Hwang, Dae Wook ^a   Lim, Chang Sup ^a   Lee, Hee Eun ^a   Kim, Woo Ho ^a   Kim, Sun Whe ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Dankook University   (South Korea)

Author keywords

Intraductal papillary mucinous tumor of pancreas; K ras mutation; Malignancy; MUC

Indexed keywords

ASPARTIC ACID; BIOLOGICAL MARKER; CALVASCULIN; DNA; GLYCINE; MUCIN 1; MUCIN 2; MUCIN 5AC; PROTEIN S 100; VALINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER MORPHOLOGY; CANCER MORTALITY; CANCER SURVIVAL; CODON; CONTROLLED STUDY; DISEASE MARKER; DISTANT METASTASIS; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MALIGNANT NEOPLASTIC DISEASE; MUTATIONAL ANALYSIS; ONCOGENE K RAS; PANCREAS RESECTION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME; UPREGULATION;

ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, PANCREATIC DUCTAL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCIN-2; MUTATION; NEOPLASM STAGING; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; S100 PROTEINS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 70049108115     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-009-0105-7     Document Type: Article

References (31)

1. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-87.
2. Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, et al. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas. 2007;35:348-52.
3. Takaori K. Current understanding of precursors to pancreatic cancer. J Hepatobiliary Pancreat Surg. 2007;14:217-23.
4. Yoshizawa K, Nagai H, Sakurai S, Hironaka M, Morinaga S, Saitoh K, et al. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas. Virchows Arch. 2002;441:437-43.
5. Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, et al. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions. J Pathol. 2002;197:632-7.
6. Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: When can we operate or observe? Ann Surg Oncol. 2008;15:199-205.
7. Jang JY, Kim SW, Ahn YJ, Yoon YS, Choi MG, Lee KU, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: Is it possible to predict the malignancy before surgery? Ann Surg Oncol. 2005;12:124-32.
8. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
9. Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143:639-46.
10. Yonezawa S, Horinouchi M, Osako M, et al. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: Its relationship with the biological behavior of the tumor. Pathol Int. 1999;49:45-54.
11. Lüttges J, Zamboni G, Longnecker D, Klöppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol. 2001;25:942-8.
12. Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: A consensus study. Virchows Arch. 2005;447:794-9.
13. Klöppel G, Solcia E, Longnecker DS, et al. Histological typing of tumours of the exocrine pancreas, WHO International histological classification of tumours. 2nd ed. Tokyo: Springer; 1996.
14. Park JH, Kim IJ, Kang HC, Shin Y, Park HW, Jang SG, et al. Oligonucleotide microarray-based mutation detection of the K-ras gene in colorectal cancers with use of competitive DNA hybridization. Clin Chem. 2004;50:1688-91.
15. Z'graggen K, Rivera JA, Compton CC, Pins M, Werner J, Fernández-del Castillo C, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg. 1997;226:491-8.
16. Kaino M, Kondoh S, Okita S, Hatano S, Shiraishi K, Kaino S, et al. Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors. Pancreas. 1999;18:294-9.
17. Biankin AV, Biankin SA, Kench JG, Morey AL, Lee CS, Head DR, et al. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut. 2002;50:861-8.
18. Kondo H, Sugano K, Fukayama N, Hosokawa K, Ohkura H, Ohtsu A, et al. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas. Cancer. 1997;79:900-5.
19. Schönleben F, Qiu W, Bruckman KC, Ciau NT, Li X, Lauerman MH, et al. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas. Cancer Lett. 2007;249:242-8.
20. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: An investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994;425:357-67.
21. Hoshi T, Imai M, Ogawa K. Frequent K-ras mutations and absence of p53 mutations in mucin-producing tumors of the pancreas. J Surg Oncol. 1994;55:84-91.
22. Izawa T, Obara T, Tanno S, Mizukami Y, Yanagawa N, Kohgo Y, et al. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas. Cancer. 2001;92:1807-17.
23. Kobayashi N, Inamori M, Fujita K, Fujisawa T, Fujisawa N, Takahashi H, et al. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms. J Hepatobiliary Pancreat Surg. 2008;15:169-77.
24. Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem. 2006;281:677-80.
25. Oida Y, Yamazaki H, Tobita K, Mukai M, Ohtani Y, Miyazaki N, et al. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer. Oncol Rep. 2006;16:457-63.
26. Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol. 2002;160:45-50.
27. Sato N, Fukushima N, Maitra A, Iacobuzio-Donahue CA, van Heek NT, Cameron JL, et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol. 2004;164:903-14.
28. Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS. Intraductal papillary-mucinous neoplasms of the pancreas: An analysis of in situ and invasive carcinomas in 28 patients. Cancer. 2002;94:62-77.
29. Yonezawa S, Nakamura A, Horinouchi M, Sato E. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobiliary Pancreat Surg. 2002;9:328-41.
30. Yonezawa S, Taira M, Osako M, Kubo M, Tanaka S, Sakoda K, et al. MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int. 1998;48:319-22.
31. Nakamura A, Horinouchi M, Goto M, Nagata K, Sakoda K, Takao S, et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: Its relationship with potential for malignancy. J Pathol. 2002;197:201-10.